Guillaume Lebreton to Risk Factors
This is a "connection" page, showing publications Guillaume Lebreton has written about Risk Factors.
Connection Strength
0.067
-
Benefits of Impella and Peripheral Veno-Arterial Extra Corporeal Life Support Alliance. ASAIO J. 2019 Nov/Dec; 65(8):837-844.
Score: 0.025
-
Clinical manifestations and outcomes of coronavirus disease-19 in heart transplant recipients: a multicentre case series with a systematic review and meta-analysis. Transpl Int. 2021 04; 34(4):721-731.
Score: 0.007
-
Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk. Transplantation. 2019 07; 103(7):1439-1449.
Score: 0.006
-
Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: Epidemiology and risk factors of treatment failure. PLoS One. 2018; 13(4):e0194976.
Score: 0.006
-
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. EuroIntervention. 2018 04 06; 13(18):e2160-e2168.
Score: 0.006
-
Assessment of potential heart donors: A statement from the French heart transplant community. Arch Cardiovasc Dis. 2018 Feb; 111(2):126-139.
Score: 0.006
-
Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: Any impact on their outcomes? J Thorac Cardiovasc Surg. 2018 04; 155(4):1621-1629.e2.
Score: 0.006
-
Extracorporeal Membrane Oxygenation for Acute Decompensated Heart Failure. Crit Care Med. 2017 Aug; 45(8):1359-1366.
Score: 0.005